Education
About Us
Working with TipRanks
Follow Us
Biolife Sciences Inc. (BLFE)
:BLFE
BLFE Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume40.00
Average Volume (3M)N/A
Market Cap
$1.57K
Enterprise Value$156.68K
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-171.37
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,566,831,800
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap99.99
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
BLFE FAQ
What was Biolife Sciences Inc.’s price range in the past 12 months?
Currently, no data Available
What is Biolife Sciences Inc.’s market cap?
Biolife Sciences Inc.’s market cap is $1.57K.
When is Biolife Sciences Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biolife Sciences Inc.’s earnings last quarter?
Currently, no data Available
Is Biolife Sciences Inc. overvalued?
According to Wall Street analysts Biolife Sciences Inc.’s price is currently Overvalued.
Does Biolife Sciences Inc. pay dividends?
Biolife Sciences Inc. does not currently pay dividends.
What is Biolife Sciences Inc.’s EPS estimate?
Biolife Sciences Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biolife Sciences Inc. have?
Biolife Sciences Inc. has 1,566,831,800 shares outstanding.
What happened to Biolife Sciences Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biolife Sciences Inc.?
Currently, no hedge funds are holding shares in BLFE
Company Description
Biolife Sciences Inc.
Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature screening technology. It offers disinfecting wipes, UV sterilization technology, electrostatic disinfection services, anti-microbial textiles, and touchless vending/marketplaces products. Bio Life Sciences Corp. was incorporated in 2018 and is based in Mississauga, Canada.
Harvard Bioscience
―
InfuSystem Holdings
―
Milestone Scientific
―
Femasys
―
Meihua International Medical Technologies Co., Ltd.
―